Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women

H. Dele Davies, Mark A. Miller, Sebastian Faro, Dan Gregson, Sue C. Kehl, Jeanne A. Jordan

Research output: Contribution to journalArticle

120 Citations (Scopus)

Abstract

Background. Current prevention of infection due to group B Streptococcus (GBS) involves giving intrapartum antibiotics to women on the basis of either antenatal culture colonization status or presence of risk factors. Methods. We prospectively compared the performance characteristics of a rapid molecular diagnostic test (IDI-Strep B; Infectio Diagnostic) with culture for intrapartum GBS detection after 36 weeks' gestation in 5 North American centers during the period September 2001-May 2002. Antenatal GBS screening was done according to the usual practice of participating hospitals. Two combined vaginal/anal specimens were obtained from participants during labor by use of standard techniques and processed by the same laboratories that processed the antenatal specimens. Each swab sample was processed simultaneously by culture and with IDI-Strep B. The collected specimens were randomized for order of testing of the swab samples by culture or the rapid test. Results. Of enrolled women, 803 (91.1%) were eligible for analysis. The overall intrapartum GBS colonization rate by culture was 18.6% (range, 9.1%-28.7%). Compared with intrapartum culture, the molecular test had a sensitivity of 94.0% (range, 90.1%-97.8%), specificity of 95.9% (range, 94.3%-97.4%), positive predictive value of 83.8% (range, 78.2%-89.4%), and negative predictive value of 98.6% (range, 97.7%-99.5%). The molecular test was superior to antenatal cultures (sensitivity, 94% vs. 54%; P < .0001) and prediction of intrapartum status on the basis of risk factors (sensitivity, 94% vs. 42%; P < .0001). Conclusion. Use of this test for determination of GBS colonization during labor is highly sensitive and specific and may lead to a further reduction in rates of neonatal GBS disease.

Original languageEnglish (US)
Pages (from-to)1129-1135
Number of pages7
JournalClinical Infectious Diseases
Volume39
Issue number8
DOIs
StatePublished - Oct 15 2004

Fingerprint

Streptococcus agalactiae
Multicenter Studies
Pregnant Women
Molecular Pathology
Routine Diagnostic Tests
Anti-Bacterial Agents
Pregnancy
Infection

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. / Davies, H. Dele; Miller, Mark A.; Faro, Sebastian; Gregson, Dan; Kehl, Sue C.; Jordan, Jeanne A.

In: Clinical Infectious Diseases, Vol. 39, No. 8, 15.10.2004, p. 1129-1135.

Research output: Contribution to journalArticle

Davies, H. Dele ; Miller, Mark A. ; Faro, Sebastian ; Gregson, Dan ; Kehl, Sue C. ; Jordan, Jeanne A. / Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. In: Clinical Infectious Diseases. 2004 ; Vol. 39, No. 8. pp. 1129-1135.
@article{51fa805ade224f8d90de83c2f475ef4c,
title = "Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women",
abstract = "Background. Current prevention of infection due to group B Streptococcus (GBS) involves giving intrapartum antibiotics to women on the basis of either antenatal culture colonization status or presence of risk factors. Methods. We prospectively compared the performance characteristics of a rapid molecular diagnostic test (IDI-Strep B; Infectio Diagnostic) with culture for intrapartum GBS detection after 36 weeks' gestation in 5 North American centers during the period September 2001-May 2002. Antenatal GBS screening was done according to the usual practice of participating hospitals. Two combined vaginal/anal specimens were obtained from participants during labor by use of standard techniques and processed by the same laboratories that processed the antenatal specimens. Each swab sample was processed simultaneously by culture and with IDI-Strep B. The collected specimens were randomized for order of testing of the swab samples by culture or the rapid test. Results. Of enrolled women, 803 (91.1{\%}) were eligible for analysis. The overall intrapartum GBS colonization rate by culture was 18.6{\%} (range, 9.1{\%}-28.7{\%}). Compared with intrapartum culture, the molecular test had a sensitivity of 94.0{\%} (range, 90.1{\%}-97.8{\%}), specificity of 95.9{\%} (range, 94.3{\%}-97.4{\%}), positive predictive value of 83.8{\%} (range, 78.2{\%}-89.4{\%}), and negative predictive value of 98.6{\%} (range, 97.7{\%}-99.5{\%}). The molecular test was superior to antenatal cultures (sensitivity, 94{\%} vs. 54{\%}; P < .0001) and prediction of intrapartum status on the basis of risk factors (sensitivity, 94{\%} vs. 42{\%}; P < .0001). Conclusion. Use of this test for determination of GBS colonization during labor is highly sensitive and specific and may lead to a further reduction in rates of neonatal GBS disease.",
author = "Davies, {H. Dele} and Miller, {Mark A.} and Sebastian Faro and Dan Gregson and Kehl, {Sue C.} and Jordan, {Jeanne A.}",
year = "2004",
month = "10",
day = "15",
doi = "10.1086/424518",
language = "English (US)",
volume = "39",
pages = "1129--1135",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women

AU - Davies, H. Dele

AU - Miller, Mark A.

AU - Faro, Sebastian

AU - Gregson, Dan

AU - Kehl, Sue C.

AU - Jordan, Jeanne A.

PY - 2004/10/15

Y1 - 2004/10/15

N2 - Background. Current prevention of infection due to group B Streptococcus (GBS) involves giving intrapartum antibiotics to women on the basis of either antenatal culture colonization status or presence of risk factors. Methods. We prospectively compared the performance characteristics of a rapid molecular diagnostic test (IDI-Strep B; Infectio Diagnostic) with culture for intrapartum GBS detection after 36 weeks' gestation in 5 North American centers during the period September 2001-May 2002. Antenatal GBS screening was done according to the usual practice of participating hospitals. Two combined vaginal/anal specimens were obtained from participants during labor by use of standard techniques and processed by the same laboratories that processed the antenatal specimens. Each swab sample was processed simultaneously by culture and with IDI-Strep B. The collected specimens were randomized for order of testing of the swab samples by culture or the rapid test. Results. Of enrolled women, 803 (91.1%) were eligible for analysis. The overall intrapartum GBS colonization rate by culture was 18.6% (range, 9.1%-28.7%). Compared with intrapartum culture, the molecular test had a sensitivity of 94.0% (range, 90.1%-97.8%), specificity of 95.9% (range, 94.3%-97.4%), positive predictive value of 83.8% (range, 78.2%-89.4%), and negative predictive value of 98.6% (range, 97.7%-99.5%). The molecular test was superior to antenatal cultures (sensitivity, 94% vs. 54%; P < .0001) and prediction of intrapartum status on the basis of risk factors (sensitivity, 94% vs. 42%; P < .0001). Conclusion. Use of this test for determination of GBS colonization during labor is highly sensitive and specific and may lead to a further reduction in rates of neonatal GBS disease.

AB - Background. Current prevention of infection due to group B Streptococcus (GBS) involves giving intrapartum antibiotics to women on the basis of either antenatal culture colonization status or presence of risk factors. Methods. We prospectively compared the performance characteristics of a rapid molecular diagnostic test (IDI-Strep B; Infectio Diagnostic) with culture for intrapartum GBS detection after 36 weeks' gestation in 5 North American centers during the period September 2001-May 2002. Antenatal GBS screening was done according to the usual practice of participating hospitals. Two combined vaginal/anal specimens were obtained from participants during labor by use of standard techniques and processed by the same laboratories that processed the antenatal specimens. Each swab sample was processed simultaneously by culture and with IDI-Strep B. The collected specimens were randomized for order of testing of the swab samples by culture or the rapid test. Results. Of enrolled women, 803 (91.1%) were eligible for analysis. The overall intrapartum GBS colonization rate by culture was 18.6% (range, 9.1%-28.7%). Compared with intrapartum culture, the molecular test had a sensitivity of 94.0% (range, 90.1%-97.8%), specificity of 95.9% (range, 94.3%-97.4%), positive predictive value of 83.8% (range, 78.2%-89.4%), and negative predictive value of 98.6% (range, 97.7%-99.5%). The molecular test was superior to antenatal cultures (sensitivity, 94% vs. 54%; P < .0001) and prediction of intrapartum status on the basis of risk factors (sensitivity, 94% vs. 42%; P < .0001). Conclusion. Use of this test for determination of GBS colonization during labor is highly sensitive and specific and may lead to a further reduction in rates of neonatal GBS disease.

UR - http://www.scopus.com/inward/record.url?scp=4644315386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644315386&partnerID=8YFLogxK

U2 - 10.1086/424518

DO - 10.1086/424518

M3 - Article

C2 - 15486835

AN - SCOPUS:4644315386

VL - 39

SP - 1129

EP - 1135

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 8

ER -